Patent details

EP3831394 Title: CROSS-LINKED CHONDROITIN SULFATE, COMPOSITION CONTAINING SAME, AND TREATMENT AGENT FOR EYE DISEASE

Basic Information

Publication number:
EP3831394
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP211507017
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
CROSS-LINKED CHONDROITIN SULFATE, COMPOSITION CONTAINING SAME, AND TREATMENT AGENT FOR EYE DISEASE
French Title of Invention:
SULFATE DE CHONDROÏTINE RÉTICULÉ, COMPOSITION LE CONTENANT ET AGENT DE TRAITEMENT DE MALADIES OCULAIRES
German Title of Invention:
VERNETZTES CHONDROITINSULFAT, ZUSAMMENSETZUNG DAMIT UND BEHANDLUNGSMITTEL FÜR AUGENERKRANKUNGEN
SPC Number:

Dates

Filing date:
15/01/2016
Grant date:
21/12/2022
EP Publication Date:
09/06/2021
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
21/12/2022
EP B1 Publication Date:
21/12/2022
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
15/01/2023
Expiration date:
15/01/2036
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
14/12/2022
 
 

Name:
Seikagaku Corporation
Address:
6-1, Marunouchi 1-chome Chiyoda-ku, Tokyo 100-0005, Japan (JP)

Inventor

Name:
FUNAYAMA, Sho
Address:
Japan (JP)

Priority

1

Priority Number:
2015007072
Priority Date:
16/01/2015
Priority Country:
Japan (JP)

2

Priority Number:
2015150976
Priority Date:
30/07/2015
Priority Country:
Japan (JP)

Classification

IPC classification:
A61K 31/738; A61P 27/02; C08B 37/00;

Publication

European Patent Bulletin

Issue number:
202251
Publication date:
21/12/2022
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages